Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Cited by (629)

Items 601–629 of 629

1. Chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) – Mepolizumab überzeugt in Real-World-Studien
   2024 · Laryngo-Rhino-Otologie
2. Treatment of Nasal Polyposis with Biologics
   Jarno De Craemer, Claus Bachert, Thibaut Van Zele, Philippe Gevaert · 2024 · Springer eBooks
3. Where Are We in the Medical Treatment of CRS with Nasal Polyps/Eosinophilic Chronic Rhinosinusitis
   Valerie Joan Lund · 2024 · Springer eBooks
4. Poliposis nasosinusal, rinosinusitis crónica con pólipos
   G. Mortuaire · 2024 · EMC - Otorrinolaringología
5. Severe asthma: biologic therapy
   Nadezhda P. Knyazheskaya, A. P. Belevskiy, Daria S. Fomina, Dmitry G. Soldatov · 2024
6. Poliposi nasosinusale, rinosinusite cronica con polipi
   G. Mortuaire · 2024 · EMC - Otorinolaringoiatria
7. Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
   Sven Becker · 2025 · HNO
8. Research Progress on the Pathogenesis of Chronic Rhinosinusitis
   晓露 李 · 2025 · Advances in Clinical Medicine
9. 19 Medical Therapies for Chronic Rhinosinusitis: Anti-Inflammatory StrategiesChronic rhinosinusitis (CRS), medical therapies for
   2025 · Thieme Medical Publishers eBooks
10. 15 Nasal PolypsNasal polyps
    2025 · Thieme Medical Publishers eBooks
11. Bibliometric analysis of biologic treatments for chronic rhinosinusitis
    Yue Sheng Huang, Yulan Chen, Qihong Li, Wen Sui, Zhuo Pan, Hao Yang, Zeyi Lv, Xi Chen, Man Yin, Yu Li et al. · 2025 · Frontiers in Medicine
12. Comparative efficacy and safety of monoclonal antibodies biologic therapies for chronic rhinosinusitis with nasal polyps: A systematic review and network meta-analysis
    Abdulhakeem Almutairi, Lina Yousef Aloraini, Bader Muzhier Alshahrani, Maan Omar Alzuhairi, Rabab Hussain Alzanadi, Khalid Alanazi, Yahya Ali Khubrani, Ahmed Y. Azzam · 2025 · American Journal of Otolaryngology
13. Additional file 1 of Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
    Gibson, Peter G., Charlene M. Prazma, Geoffrey Lowell Chupp, Eric Bradford, Mark S. Forshag, Mallett, Stephen A., Yancey, Steve W., Smith, Steven G., Elisabeth H. Bel · 2021 · Figshare
14. Additional file 1 of Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
    Wytske Johanna Fokkens, Andrew Trigg, Lee, Stella E., Robert H. Chan, Diamant, Zuzana, Claire L Hopkins, Howarth, Peter, Valerie Joan Lund, Bhabita Mayer, Ana R. Sousa et al. · 2023 · Figshare
15. Aspirin-Exacerbated Respiratory Disease
    Mark Arnold, Joshua M. Levy · 2025 · Springer eBooks
16. Outcomes of Maximal Conventional Therapy Before Biological Treatment in Recurrent Chronic Rhinosinusitis With Nasal Polyps
    Yunus Emre Topan, Nuray Bayar Muluk, Ramazan Yavuz, Necat Alataş, Cemal Cingi · 2026 · Journal of Craniofacial Surgery
17. Polypose naso-sinusienne : rôle des facteurs inflammatoires dans les dysfonctions épithéliales et perspectives thérapeutiques
    Émilie Béquignon · 2019 · theses.fr (ABES)
18. Impact du microbiote et de la réponse inflammatoire de type 2 (lgE et éosinophiles) en contexte allo-immun : l'exemple de la transplantation rénale
    Luc Colas · 2021 · theses.fr (ABES)
19. Targeting Type-2 inflammation in chronic rhinosinusitis with nasal polyps: mechanisms, eosinophilia, and emerging therapies
    Sahar Khorasani, Mohammad Hasan Yousefi, Somayeh Safarirad, Hamed Afkhami, Azin Khodadadi · 2026 · European journal of medical research
20. Real-world impact of mepolizumab on symptom control and health utility in severe chronic rhinosinusitis with nasal polyps: the RINOSUR 2.0 multicenter cohort study
    Rocio Corrales-Millán, Juan Maza‐Solano, Juan Ramón Benito Navarro, Virginia García‐García, María José Gámiz-Maroto, Juan Andrés Márquez-Moyano, Lucía Prieto-Sánchez-de-Puerta, Andrés Caballero García, Dionisio Guillamón-Fernández, Manuel Ortiz-Rueda et al. · 2026 · European Archives of Oto-Rhino-Laryngology
21. Real-Life Effectiveness of Mepolizumab in Severe Type-2 Chronic Rhinosinusitis with Nasal Polyps: Clinical Outcomes and Predictors of Response
    Sante De Santis, Stefania Galassi, Jacopo Cambi · 2026 · International Archives of Allergy and Immunology
22. Eosinophils as immunoregulatory players in allergic rhinitis: beyond cytotoxicity
    X D Han, Feng Li, Feihu Wu, Chunsong Liu, Qiqi Yang, Yan Ruan, Weiping He, Wenda Feng, Gang Liu, Chunqiao Li · 2026 · Frontiers in Immunology
23. Improved VO 2 max following anti-IL-5 therapy in severe eosinophilic CRSwNP: exploratory associations with cardiac inflammatory biomarkers
    Jens Even Tidemandsen, K Rossing, Anne‐Sophie Homøe, Morten Hostrup, Vibeke Backer · 2026 · European Clinical Respiratory Journal
24. Uncontrolled Status, Disease Burden, and Associated Risk Factors Among Patients with Asthma Receiving Medium-to-High Dose ICS or ICS/LABA: A Retrospective Analysis
    Honglei Shi, Ying Wang, Min Wang, Dan Shen, Huang Kw · 2026 · Advances in Therapy
25. Dose tapering and treatment de-escalation of biologic therapies in chronic rhinosinusitis with nasal polyps: a narrative review
    Salma Alsharhan, Hussain J Aljubran · 2026 · Frontiers in Surgery
26. Postoperative Management of Patients with Eosinophilic Chronic Rhinosinusitis
    Kosuke Akiyama · 2026 · Practica Oto-Rhino-Laryngologica
27. Role of Nasal Endoscopy in Diagnosis of ENP
    Sara Maurantonio, Goran Latif Omer, Sahand Soran Ali, Rekawt Hama Rashid Kareem, Iacopo Dallan, Stefano Di Girolamo, Roy R. Casiano · 2026 · Springer eBooks
28. Biologic Therapies for ENP: Anti–IL-4, IL-5, and IL-13 Pathways
    Mohamed Samy Elwany, Mohamed Shehata Taha · 2026 · Springer eBooks
29. Chronic Rhinosinusitis with Nasal Polyps: T-Cell Dysregulation and Regulatory T-Cell Dysfunction
    Ebrahim Farashi, Tolani F. Olonisakin, Joshua M. Levy, Nyall R. London · 2026 · Current Otorhinolaryngology Reports